Fiabilidad de los predictores clínicos y de la biopsia de arteria ...

Fiabilidad de los predictores clínicos y de la biopsia de arteria temporal en el diagnóstico de la arteritis de células gigantes
Joan Brunsó Casellas
227- Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A,
Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with
methotrexate and prednisone: a randomized, double-blind, placebocontrolled
trial. Ann Intern Med. 2001;134:106-114.
228- Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Schousboe J, Cohen P, et
al. A multicenter, randomized, double-blind, placebo-controlled trial of
adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum.
2002;46:1309-1318.
229- Cantini F, Niccoli L, Salvarani C, Padula A, Olivieri I. Treatment of
longstanding active giant cell arteritis with infliximab: report of four cases.
Arthritis Rheum. 2001;44:2933-5.
230- Cantini F, Niccoli L, Nannini C, Bertoni M, Salvarani C. Diagnosis and
treatment of giant cell arteritis. Drug Aging. 2008; 25(4): 281-297.
231- Martinez-Taboada VM, Rodriguez-Valverde V, Carreno L, Lopez-Longo J,
Figueroa M, Belzunegui J, et al. A doublé-blind placebo controlled trial of
etanercept in patients with giant cell arteritis and corticosteroid side effects.
Ann Rheum Dis. 2008; 67(5):625-630.
232- Hoffman GS, Cid M, Rendt-Zagar K, Merkel P, Weyand C, Stone J, et
al.Infliximab for manintenance of glucocorticosteroid-induced remission of
giant cell arteritis. Ann Intern Med. 2007; 146:621-630.
233- Sailler L, Carreiro M, Ollier S, Juchet H, Delobel P, Ferrand D, et al. Noncomplicated
Horton's disease: initial treatment with methylprednisolone 500
mg/day bolus for three days followed by 20 mg/day prednisone-equivalent:
evaluation of 15 patients. Rev Med Interne. 2001;22:1032-8.
234- Mazlumzadeh M, Calamia KT, Matteson EL. High dose pulse intravenous
glucocorticoid infusion as the initial treatment of giant cell arteritis. Arthritis
Rheum. 2004;50:269.
235- Spiera RF, Kupersmith M, Paget S, et al.: Vision loss in giant cell arteritis
patients treated with alternate-day corticosteroids: comment on the article by
Hoffman et al. Arthritis Rheum .2003; 48:1158-1170.
236- Hunder GG, Sheps SG, Allen GL. Daily and alternate-day corticosteroid
regimens in treatment of giant cell arteritis: comparison in a prospective
study. Ann Intern Med .1975; 82:613-8.
237- Bengtsson BA, Malmvall BE. An alternate-day corticosteroid regimen in
maintenance therapy of giant cell arteritis. Acta Med Scand .1981; 209:347-
350.
238- Ruegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss. A
166